---
title: "Nexalin Technology, Inc. (NXL.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NXL.US.md"
symbol: "NXL.US"
name: "Nexalin Technology, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-19T22:48:23.808Z"
locales:
  - [en](https://longbridge.com/en/quote/NXL.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NXL.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NXL.US.md)
---

# Nexalin Technology, Inc. (NXL.US)

## Company Overview

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.nexalin.com](https://www.nexalin.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:12.000Z

**Overall: C (0.46)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 113 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 110.26% |  |
| Net Profit YoY | 2.61% |  |
| P/B Ratio | 2.31 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 6678744.13 |  |
| Revenue | 275582.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -319.69% | E |
| Profit Margin | -3022.94% | E |
| Gross Margin | 87.85% | A |
| Revenue YoY | 110.26% | A |
| Net Profit YoY | 2.61% | C |
| Total Assets YoY | 27.40% | A |
| Net Assets YoY | 24.12% | A |
| Cash Flow Margin | 62.95% | C |
| OCF YoY | 110.26% | A |
| Turnover | 0.08 | E |
| Gearing Ratio | 21.88% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Nexalin Technology, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "110.26%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "2.61%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.31",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "6678744.13",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "275582.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-319.69%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-3022.94%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "87.85%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "110.26%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "2.61%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "27.40%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "24.12%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "62.95%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "110.26%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.08",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "21.88%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.80 | 81/183 | - | - | - |
| PB | 2.31 | 64/183 | 7.21 | 2.73 | 2.10 |
| PS (TTM) | 24.24 | 129/183 | 136.88 | 90.61 | 51.84 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-07T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.32 |
| Highest Target | 2.00 |
| Lowest Target | 2.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/NXL.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/NXL.US/norm.md)
- [Related News](https://longbridge.com/en/quote/NXL.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/NXL.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**